Kings Path Partners »

Recursion Pharmaceuticals shares owned by Kings Path Partners

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.6k 1.0k 6.59

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Schwab Strategic Tr Us Tips Etf (SCHP)

View all positions for Kings Path Partners

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
BlackRock
BlackRock
RA Capital Management
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
State Street Corporation
MIC Capital Management UK
Nvidia Corp
Geode Capital Management
Exor Investments

View all funds holding Recursion Pharmaceuticals